搜索筛选:
搜索耗时0.0881秒,为你在为你在102,285,761篇论文里面共找到 22 篇相符的论文内容
发布年度:
[期刊论文] 作者：Wei Zhu,Ruihua Xu,,
来源：Journal of Traffic and Transportation Engineering(English Ed 年份：2016
In recent years,the metro system has advanced into an efficient transport system and become the mainstay of urban passenger transport in many mega-cities.Passen...
MET overexpression / amplification predicts the inhibitory effects of anti-MET activity in gastric c
[会议论文] 作者：Miaozhen Qiu,Ruihua Xu,
来源：第十二届国际胃癌学术会议 年份：2017
...
Study protocol of the Asian XELIRI ProjecT（AXEPT）：a multinational,randomized,non-inferiority,phase Ⅲ
[期刊论文] 作者：Masahito Kotaka,Ruihua Xu,Kei,
来源：癌症：英文版 年份：2016
Colorectal cancer(CRC)results from the progressive accumulation of genetic and epigenetic alterations that lead to the transformation of normal colonic mucosa t...
Study protocol of the Asian XELIRI ProjecT (AXEPT)：a multinational, randomized, non-inferiority, pha
[期刊论文] 作者：Masahito Kotaka,Ruihua Xu,Kei,
来源：黑龙江科技学院学报 年份：2016
为探究吕家坨井田地质构造格局,根据钻孔勘探资料,采用分形理论和趋势面分析方法,研究了井田7...
Oxaliplatin, Fluorouracil and Leucovorin （FOLFOX） as First-line Chemotherapy for Metastatic or Recur
[期刊论文] 作者：Bing Han Ruihua Xu Yanxia Shi,
来源：中国肿瘤临床：英文版 年份：2007
OBJECTIVE To investigate the efficiency and safety of the oxaliplatin, fluorouracil(5-FU)and leucovorin regimen(FOLFOX)in previously untreated patients with met...
Oxaliplatin, Fluorouracil and Leucovorin (FOLFOX) as First-line Chemotherapy for Metastatic or Recur
[期刊论文] 作者：Bing Han,Ruihua Xu,Yanxia Shi,,
来源：中国肿瘤临床（英文版） 年份：2007
OBJECTIVE To investigate the efficiency and safety of the oxaliplatin,fluorouracil (5-FU) and leucovorin regimen (FOLFOX) in previously untreated patients with...
A corpus-based contrastive study on the phraseological patterns of exemplification in Chinese EFL le
[会议论文] 作者：Shucai Guo,Na Li,Ruihua Xu,
来源：Corpus Technologies & Applied Linguistics : An Internati 年份：2012
...
[会议论文] 作者：Miaozhen Qiu,Caiyun He,Ruihua Xu,
来源：第十三届全国胃癌学术会议 年份：2018
Objective Nine percent of tumors in the TCGA study were assigned to be EBVassociated gastric carcinoma(EBVaGC)....
A corpus-based contrastive study on the phraseological patterns of exemplification in Chinese EFL le
[会议论文] 作者：Shucai Guo,Na Li,Ruihua Xu,
来源：中国西安利物浦大学 年份：2012
...
Oxaliplatin, Fluorouracil and Leucovorin (FOLFOX) as First-line Chemotherapy for Metastatic or Recur
[期刊论文] 作者：Bing Han,Ruihua Xu,Yanxia Shi,Huiyan Luo,Xiaojuan Xiang,Yuhong Li,Li Zhang,Tongyu Lin,Youjian He,
来源：中国肿瘤临床（英文版） 年份：2004
OBJECTIVE To investigate the efficiency and safety of the oxaliplatin,fluorouracil (5-FU) and leucovorin regimen (FOLFOX) in previously untreated patients with...
The result of Phase 1b and phase 2 study of selective VEGFR inhibitor fruquintinib as 3+ line therap
[会议论文] 作者：Jin Li,Ruihua Xu,Junning Cao,Yuxian Bai,Jianming Xu,Tianshu Liu,Lin Shen,Liwei Wang,Hongming Pan,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: Fruquintinib is a novel oral small molecule compound selectively inhibits vascular endothelial growth factor receptors (VEGFR)1, 2, and 3 with potent inhibitory effects on multiple human tu...
Clinical significance of cell free tumor DNA detection in predicting prognosis in advanced gastric c
[会议论文] 作者：Shuqiang Yuan,Qi Zhao,Mingming He,Runcong Nie,Yuhong Li,Fenghua Wang,Yingbo Chen,Zhiwei Zhou,Feng Wang,Ruihua Xu,
来源：第十二届国际胃癌学术会议 年份：2017
Objective: In order to investigate the feasibility and prognostic significance of cell free tumor DNA detection in gastric cancer patients....
Evaluation of tumor MET protein expression, MET gene amplification, and HER2 expression in Chinese p
[会议论文] 作者：Qiu Miaozhen,Ruihua Xu,Yixin Zhou,Deshen Wang,Dongsheng Zhang,Fenghua Wang,Yuhong Li,Jacqueline Huang,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: Gastric cancer is a disease with high unmet medical needs in China.MET and its ligand, hepatocyte growth factor, are potential targets in G/GEJ cancer....
[期刊论文] 作者：Xicheng Wang,Gong Chen,Yi Wang,Weiqi Sheng,Xinxiang Li,Aiping Zhou,Zhen Zhang,Guichao Li,Sanjun Cai,Ruihua Xu,
来源：中国癌症研究（英文版） 年份：2019
According to the latest data from cancer registration center,there are estimated to be 3,929,000 individuals newly diagnosed with cancer and 2,338,000 deaths fr...
[期刊论文] 作者：Miaomiao Dai,Chi Zhang,Kai Teng,Fengwei Wang,Hongbo Li,Weipeng Sun,Zihao Feng,Tiebang Kang,Xinyuan Guan,Ruihua Xu,
来源：蛋白质与细胞 年份：2021
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and is the fourth-leading cause of cancer-related deaths worldwide.HCC is refractory to many standard cancer treatments and the prognosis is often poor,highlighting ......
[期刊论文] 作者：Xicheng Wang,Gong Chen,Yi Wang,Weiqi Sheng,Xinxiang Li,Aiping Zhou,Zhen Zhang,Guichao Li,Sanjun Cai,Ruihua Xu,
来源：中国癌症研究（英文版） 年份：2020
According to the latest data released by the National Cancer Center, colorectal cancer (CRC) had the third highest incidence and the fifth highest mortality of...
Continuing single-agent capecitabin as maintenance therapy after induction of XELOX (or FOLFOX) in f
[会议论文] 作者：Ruihua Xu,Yuhong Li,Huiyan Luo,Wei Wang,Zhiqiang Wang,Xia Yuan,Dong Ma,Fenghua Wang,Dongshen Zhang,Daren,
来源：第十八届全国临床肿瘤学大会暨2015年CSCO学术年会 年份：2015
Objective: Colorectal cancer (CRC) is one of the most common malignant tumors.Most of advanced CRC will progress after first-line treatment;therefore, seeking an efficient and low toxic maintaining re...
Study protocol of the Asian XELIRI ProjecT(AXEPT):a multinational,randomized,non-inferiority,phase Ⅲ
[期刊论文] 作者：Masahito Kotaka,Ruihua Xu,Kei Muro,Young Suk Park,Satoshi Morita,Satoru Iwasa,Hiroyuki Uetake,Tomohiro,
来源：Chinese Journal of Cancer 年份：2016
Background: Capecitabine and irinotecan combination therapy(XELIRI) has been examined at various dose levels to treat metastatic colorectal cancer(m CRC). Recen...
Efficacy and safety of chemotherapy combined with bevacizumab in Chinese patients with metastatic co
[期刊论文] 作者：Zuoxing Niu,Feng Bi,Liangjun Zhu,Zengqing Guo,Jin Yan,Bing Hu,Min Tao,Shujun Yang,Suzhan Zhang,Lu Wen,Ruihua Xu,
来源：中国癌症研究:英文版 年份：2021
Objective:Bevacizumab has an important and evolving role in improving outcomes in patients with metastatic colorectal cancer(mCRC)worldwide and was approved in China in 2010.However,there are limited real-world data on the efficacy and safe......
[期刊论文] 作者：Ba,Yuankai Shi,Wenqi Jiang,Jifeng Feng,Ying Cheng,Li Xiao,Qingyuan Zhang,Wensheng Qiu,Binghe Xu,Ruihua Xu,
来源：癌症生物学与医学（英文版） 年份：2020
Chemotherapy-induced neutropenia (CIN) is a potentially fatal and common complication in myelosuppressive chemotherapy. The timing and grade of CIN may play pro...
相关搜索：
